Repression of HMGA2 Gene Expression by Human Cytomegalovirus Involves the IE2 86-Kilodalton Protein and Is Necessary for Efficient Viral Replication and Inhibition of Cyclin A Tran...

di Shlapobersky, Mark, Sanders, Rebecca, Clark, Charles, Spector, Deborah H.
Pubblicazione 2006

A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes

di Veselenak, Ron L., Shlapobersky, Mark, Pyles, Richard B., Wei, Qun, Sullivan, Sean M., Bourne, Nigel
Pubblicazione 2012

Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection

di Shlapobersky, Mark, Marshak, Joshua O., Dong, Lichun, Huang, Meei-li, Wei, Qun, Chu, Alice, Rolland, Alain, Sullivan, Sean, Koelle, David M.
Pubblicazione 2012

Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus

di Hartikka, Jukka, Bozoukova, Vesselina, Morrow, Jane, Rusalov, Denis, Shlapobersky, Mark, Wei, Qun, Boutsaboualoy, Sou, Ye, Ming, Wloch, Mary K., Doukas, John, Sullivan, Sean, Rolland, Alain, Smith, Larry R.
Pubblicazione 2012

Preclinical evaluation of Vaxfectin(®)-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

di Smith, Larry R., Wodal, Walter, Crowe, Brian A., Kerschbaum, Astrid, Bruehl, Peter, Schwendinger, Michael G., Savidis-Dacho, Helga, Sullivan, Sean M., Shlapobersky, Mark, Hartikka, Jukka, Rolland, Alain, Barrett, P. Noel, Kistner, Otfried
Pubblicazione 2013

Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse

di Rijensky, Nataly Mancette, Blondheim Shraga, Netta R., Barnea, Eilon, Peled, Nir, Rosenbaum, Eli, Popovtzer, Aron, Stemmer, Solomon M., Livoff, Alejandro, Shlapobersky, Mark, Moskovits, Neta, Perry, Dafna, Rubin, Eitan, Haviv, Itzhak, Admon, Arie
Pubblicato in Mol Cell Proteomics (2020)